Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review.

Mansour M, Liy Wong C, Zulian F, Li S, Morishita K, Yeh EA, Stewart K, Laxer RM, Pope E.

Pediatr Dermatol. 2018 Sep 6. doi: 10.1111/pde.13605. [Epub ahead of print]

PMID:
30187959
2.

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.

Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, Pappagallo G, Ravelli A, Taddio A, Zulian F, Cimaz R; Rheumatology Italian Study Group.

Pediatr Rheumatol Online J. 2018 Jul 11;16(1):46. doi: 10.1186/s12969-018-0255-8. Review.

3.

Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.

Bharucha KN, Brunner HI, Calvo Penadés I, Nikishina I, Rubio-Pérez N, Oliveira S, Kobusinska K, Schmeling H, Sztajnbok F, Weller-Heinemann F, Zholobova E, Zulian F, Allen R, Chaitow J, Frane J, Wells C, Ruperto N, De Benedetti F; Paediatric Rheumatology International Trials Organisation and the Pediatric Rheumatology Collaborative Study Group.

J Rheumatol. 2018 Aug;45(8):1173-1179. doi: 10.3899/jrheum.170326. Epub 2018 Jul 1.

4.

Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma.

Agazzi A, Fadanelli G, Vittadello F, Zulian F, Martini G.

Pediatr Rheumatol Online J. 2018 Jun 18;16(1):37. doi: 10.1186/s12969-018-0254-9.

5.

Scleroderma in children.

Zulian F.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):576-595. doi: 10.1016/j.berh.2018.02.004. Epub 2018 Mar 27. Review.

PMID:
29773274
6.

Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review.

Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F.

Autoimmun Rev. 2018 Jul;17(7):727-734. doi: 10.1016/j.autrev.2018.02.004. Epub 2018 May 3. Review.

PMID:
29729451
7.

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.

Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.

J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.

8.

Cone beam computed tomography for the assessment of linear scleroderma of the face.

Di Giovanni C, Puggina S, Meneghel A, Vittadello F, Martini G, Zulian F.

Pediatr Rheumatol Online J. 2018 Jan 3;16(1):1. doi: 10.1186/s12969-017-0218-5.

9.

Tocilizumab in two children with pansclerotic morphoea: a hopeful therapy for refractory cases?

Martini G, Campus S, Raffeiner B, Boscarol G, Meneghel A, Zulian F.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):211-213. Epub 2017 Sep 29.

PMID:
28980909
10.

Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis.

Meneghel A, Martini G, Birolo C, Tosoni A, Pettenazzo A, Zulian F.

Rheumatology (Oxford). 2017 Oct 1;56(10):1822-1823. doi: 10.1093/rheumatology/kex262. No abstract available.

PMID:
28957546
11.

Anti-DFS70 antibodies in healthy schoolchildren: A follow-up analysis.

Sperotto F, Seguso M, Gallo N, Plebani M, Zulian F.

Autoimmun Rev. 2017 Feb;16(2):210-211. doi: 10.1016/j.autrev.2017.01.001. Epub 2017 Jan 4. No abstract available.

PMID:
28062281
12.

Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship?

Cecchin V, Sperotto F, Balzarin M, Vittadello F, Martini G, Zulian F.

J Paediatr Child Health. 2017 Apr;53(4):374-377. doi: 10.1111/jpc.13450. Epub 2017 Jan 4.

PMID:
28052441
13.

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept.

Verazza S, Davì S, Consolaro A, Bovis F, Insalaco A, Magni-Manzoni S, Nicolai R, Marafon DP, De Benedetti F, Gerloni V, Pontikaki I, Rovelli F, Cimaz R, Marino A, Zulian F, Martini G, Pastore S, Sandrin C, Corona F, Torcoletti M, Conti G, Fede C, Barone P, Cattalini M, Cortis E, Breda L, Olivieri AN, Civino A, Podda R, Rigante D, La Torre F, D'Angelo G, Jorini M, Gallizzi R, Maggio MC, Consolini R, De Fanti A, Muratore V, Alpigiani MG, Ruperto N, Martini A, Ravelli A; Italian Pediatric Rheumatology Study Group.

Pediatr Rheumatol Online J. 2016 Dec 20;14(1):68.

14.

Update of EULAR recommendations for the treatment of systemic sclerosis.

Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors.

Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.

PMID:
27941129
15.

Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.

Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.

J Rheumatol. 2016 Nov;43(11):2068-2073. Epub 2016 Sep 15.

PMID:
27633826
16.

Recent advances in the management of juvenile systemic sclerosis.

Zulian F, Balzarin M, Birolo C.

Expert Rev Clin Immunol. 2017 Apr;13(4):361-369. doi: 10.1080/1744666X.2017.1243467. Epub 2016 Oct 11. Review.

PMID:
27690679
17.

Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis.

Frid P, Nordal E, Bovis F, Giancane G, Larheim TA, Rygg M, Pires Marafon D, De Angelis D, Palmisani E, Murray KJ, Oliveira S, Simonini G, Corona F, Davidson J, Foster H, Steenks MH, Flato B, Zulian F, Baildam E, Saurenmann RK, Lahdenne P, Ravelli A, Martini A, Pistorio A, Ruperto N; Paediatric Rheumatology International Trials Organisation.

Arthritis Care Res (Hoboken). 2017 May;69(5):677-686. doi: 10.1002/acr.23003.

18.

Synovial Hemangioma of Infrapatellar (Hoffa) Fat Pad: Magnetic Resonance Imaging and Ultrasound Features.

Beltrame V, Romanucci G, Zulian F, Stramare R.

J Pediatr. 2016 May;172:222-3. doi: 10.1016/j.jpeds.2016.01.052. Epub 2016 Feb 26. No abstract available.

PMID:
26922106
19.

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.

Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Brochard K, Corona F, Dressler F, Gerloni V, Apaz MT, Bracaglia C, Cespedes-Cruz A, Cimaz R, Couillault G, Joos R, Quartier P, Russo R, Tardieu M, Wulffraat N, Bica B, Dolezalova P, Ferriani V, Flato B, Bernard-Medina AG, Herlin T, Trachana M, Meini A, Allain-Launay E, Pilkington C, Vargova V, Wouters C, Angioloni S, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO).

Lancet. 2016 Feb 13;387(10019):671-8. doi: 10.1016/S0140-6736(15)01021-1. Epub 2015 Nov 30.

PMID:
26645190
20.

Musculoskeletal pain in schoolchildren across puberty: a 3-year follow-up study.

Sperotto F, Brachi S, Vittadello F, Zulian F.

Pediatr Rheumatol Online J. 2015 May 15;13:16. doi: 10.1186/s12969-015-0014-z.

Supplemental Content

Loading ...
Support Center